祛瘀生肌方湿敷联合西药治疗糖尿病足溃疡临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R258;R587.2

基金项目:

浙江省中医药科技计划项目(2021ZB315)


Clinical Study on Wet Compress of Quyu Shengji Prescription Combined with Western Medicine in the Treatment of Diabetic Foot Ulcer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察祛瘀生肌方湿敷联合西药治疗糖尿病足溃疡的疗效。方法:选取2021 年12 月— 2023年12月舟山市中医院收治的86例糖尿病足溃疡难愈患者,按随机数字表法分为对照组及观察组各43例。 对照组给予常规西药治疗,观察组在对照组基础上给予祛瘀生肌方湿敷治疗。2组均治疗2个月。比较2组临 床疗效,比较2组治疗前后6点行为评分法(BRS-6)、溃疡面积、足背经皮氧分压、足背动脉血管内径、血流 速度、血流量、溃疡面肉芽组织微血管密度、血管内皮生长因子(VEGF) 光密度值、血清淀粉样蛋白 A (SAA)、Toll样受体9 (TLR9)、肿瘤坏死因子-α (TNF-α)、脂蛋白相关磷脂酶A2 (Lp-PLA2) 水平的变 化。结果:观察组临床疗效总有效率为97.67%(42/43),对照组临床疗效总有效率为81.40%(35/43),2组比 较,差异有统计学意义(P<0.05)。治疗后,2组BRS-6评分均较治疗前下降,溃疡面积均较治疗前减小,经 皮氧分压均较治疗前升高,差异均有统计学意义(P<0.05);观察组BRS-6评分少于对照组,溃疡面积小于对 照组,经皮氧分压高于对照组,差异均有统计学意义(P<0.05)。治疗后,2组足背动脉血管内径、血流速度、 血流量均较治疗前增加(P<0.05),观察组足背动脉血管内径、血流速度、血流量均大于对照组(P<0.05)。 治疗后,2组微血管密度、VEGF光密度值均较治疗前提升(P<0.05),观察组微血管密度、VEGF光密度值均 高于对照组(P<0.05)。治疗后,2组SAA、TLR9、TNF-α、Lp-PLA2水平均较治疗前下降(P<0.05),观察 组SAA、TLR9、TNF-α、Lp-PLA2水平均低于对照组(P<0.05)。结论:祛瘀生肌方湿敷联合西药治疗糖尿病 足溃疡疗效较好,可抑制机体炎症反应,促进血管新生和创面修复,改善动脉血流动力学及微循环,缓解 疼痛。

    Abstract:

    Abstract:Objective:To observe the clinical effect of wet compress of Quyu Shengji Prescription combined with western medicine in the treatment of diabetic foot ulcer (DFU). Methods:A total of 86 cases of patients with refractory DFU admitted to Zhoushan Hospital of Traditional Chinese Medicine from December 2021 to December 2023 were selected and divided into the control group and the observation group according to the random number table method, with 43 cases in each group. The control group was treated with conventional western medicine, and the observation group was treated with wet compress of Quyu Shengji Prescription on the basis of the control group. Both groups were treated for two months. The clinical effects in the two groups were compared. The changes of the 6-point Behavioral Rating Scale( BRS-6) score,ulcer area,transcutaneous oxygen pressure(TcPO2) on the dorsum of the foot,internal diameter,blood flow velocity,blood flow volume of the dorsalis pedis artery,microvessel density in granulation tissue of ulcer surface, optical density of vascular endothelial growth factor (VEGF), levels of serum amyloid A (SAA), Toll-like receptor 9 (TLR9),tumor necrosis factor α (TNF-α),and lipoprotein-associated phospholipase A2 (Lp- PLA2) were compared before and after treatment in the two groups. Results:The total effective rate of clinical effect in the observation group was 97.67%(42/43), and that in the control group was 81.40%(35/43), the difference being significant (P<0.05). After treatment, the BRS-6 scores and the ulcer area in the two groups were decreased compared with those before treatment,and the TcPO2 was increased compared with that before treatment,differences being significant (P<0.05);the BRS-6 score in the observation group was lower than that in the control group,the ulcer area was smaller than that in the control group, and the TcPO2 was higher than that in the control group, differences being statistically significant (P<0.05). After treatment, the internal diameter, blood flow velocity, blood flow volume of the dorsalis pedis artery in the two groups were increased compared with those before treatment (P<0.05), and the above three indicators in the observation group were superior to those in the control group (P<0.05). After treatment,the microvessel density and optical density of VEGF in the two groups were elevated compared with those before treatment (P<0.05), and the microvessel density and optical density of VEGF in the observation group were higher than those in the control group (P<0.05). After treatment,the levels of SAA,TLR9, TNF-α,and Lp-PLA2 in the two groups were decreased compared with those before treatment (P<0.05),and the levels of SAA,TLR9,TNF-α,and Lp-PLA2 in the observation group were lower than those in the control group (P< 0.05). Conclusion:The therapy of wet compress of Quyu Shengji Prescription combined with western medicine exerts certain clinical effect in the treatment of DFU, which can inhibit the inflammatory responses of the body, promote angiogenesis and wound healing,improve arterial hemodynamics and microcirculation,and alleviate pain.

    参考文献
    相似文献
    引证文献
引用本文

戴奇明,胡蕾.祛瘀生肌方湿敷联合西药治疗糖尿病足溃疡临床研究[J].新中医,2025,57(11):74-79

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-06-13
  • 出版日期:
文章二维码